Vir Biotechnology (NASDAQ:VIR) reported its Q4 earnings results on Thursday, February 22, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Vir Biotechnology beat estimated earnings by 14.85%, reporting an EPS of $-0.86 versus an estimate of $-1.01.

Revenue was down $32.62 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 6.96% increase in the share price the next day.

Here's a look at Vir Biotechnology's past performance:

To track all earnings releases for Vir Biotechnology visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.